TAP, AVISO GmbH announce second distribution agreement to supply CellCelector stem cell picker

NewsGuard 100/100 Score

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced it has entered into a second distribution agreement with AVISO GmbH, a major German manufacturer of automation for the stem cell market. Under the terms of this new agreement, TAP will supply CellCelector™, AVISO’s unique automated stem cell picker within the UK and Ireland and will continue to service this product in the USA and Canada under the terms of its previous distribution agreement.

With the new agreement, TAP will market AVISO’s patented CellCelector stem cell picker. This non-invasive system automates selection and harvesting of a variety of murine and human stem cells, allowing scientists in the UK and Ireland to reduce the time and costs of this laborious manual process. Additionally, by accessing CellCelector’s technology, researchers can standardise the quality of cells and fully document their work with life-like images of the cells prior to and post harvesting.

Phillip Sefton, TAP’s Commercial Director states: “TAP has a dominant position in the UK automated cell culture market with installations of our CompacT SelecT in all the key pharma and biotech companies, as well as major academic institutes. Many of these scientists need a robust, reliable automated stem cell picker and we are delighted to be partnering with AVISO again to offer exclusive access to the time saving and quality benefits the unrivalled CellCelector technology will bring to their research.”

Source:

The Automation Partnership

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists uncover a cell responsible for repairing damaged liver tissue